top of page

IMPORTANT NOTICE: END-OF-LIFE ANNOUNCEMENT

SWEAT AWARE®/ CORTI™ / IBD AWARE® Device Version 3.6

Date: October 1, 2025

​

To: All SWEAT AWARE®/ CORTI™ / IBD AWARE® v3.6 Device Users

​

From: EnLiSense® CCM

​

Re: End-of-Life Notice for SWEAT AWARE®/ CORTI™ / IBD AWARE® v3.6 Device

NOTICE OF SERVICE DISCONTINUATION

​

EnLiSense hereby provides formal notice that we will be discontinuing support and services for the SWEAT AWARE®/ CORTI™ / IBD AWARE® device version 3.6, part of our EnLiSense® system, effective October 31, 2025 (the "End-of-Life Date").

Important Disclaimer

Guidance for Use and Regulatory Status

EnLiSense devices (IBD AWARE, SWEAT AWARE, and CORTI) are for general wellness in healthy individuals, supporting health awareness, fitness, and lifestyle insights. These products are positioned as low-risk general wellness devices under the FDA's "General Wellness: Policy for Low-Risk Devices" guidance issued January 6, 2026. They provide comprehensive wellness monitoring that continuously and non-invasively tracks chemical biomarkers present in sweat. Please note that our devices are not FDA-cleared and cannot be used for medical diagnostic purposes. We do provide our wearable products for clinical studies and research conducted under Institutional Review Board (IRB) oversight. The EnLiSense Wellness Platform holds commercial certifications for the general wellness category, including the CE Mark (EU), UK CA Mark (UK), and certified to FCC (USA).
 

Non General Wellness Use Requires Clinical Oversight
Medical applications, including monitoring or managing diseases are still under investigation. Investigational use require supervision by qualified healthcare professionals in clinical or research settings.
 

No Medical Claims
Mentions of biomarkers or health conditions reflect research goals and are not evaluated by the FDA. All information is for education and wellness only, not as medical advice.
 

Consult Healthcare Professionals
Consult healthcare providers regarding medical concerns or symptoms. Device data does not replace professional medical advice, diagnosis, or treatment. Seek immediate care for urgent symptoms.
 

Limitations
Users accept all risks with device use. EnLiSense is not responsible for health outcomes from device use or data interpretation. Product features and capabilities may change as development continues.

© 2023 - 2026 by EnLiSense | Terms of Service & Privacy Policy

  • LinkedIn
bottom of page